Advertisement

Current Hematologic Malignancy Reports

, Volume 13, Issue 6, pp 576–580 | Cite as

Social Media and Hematopoietic Cell Transplantation: a Review of Online Resources and Communities

  • Sagar S. Patel
  • Navneet S. MajhailEmail author
Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Social Media Impact of Hematologic Malignancies

Abstract

Purpose of Review

Social media has dramatically changed the access and exchange of information in healthcare and beyond. A variety of platforms and resources exist allowing blood and marrow transplant providers, researchers, and patients to interact. We review the adoption of social media by the transplantation community.

Recent Findings

Social media allows on-demand access to the latest developments at national and international meetings, newly published research articles, facilitates networking with colleagues, participation in advocacy, and promoting available clinical trials. For the modern transplantation provider, the scope and ease of access to these benefits are unparalleled. Social media serves as a gateway to access relevant resources and communities for both providers and patients as it pertains to transplantation.

Summary

We demonstrate the utilization and applications of social media among stem cell transplantation providers, patients, and other affiliated stakeholders. A variety of resources and communities have enhanced and increased the opportunities for engagement.

Keywords

Social media Hematopoietic cell transplantation Twitter Hashtags Handles 

Notes

Compliance with Ethical Standards

Conflict of Interest

Navneet S. Majhail reports financial support from Anthem, Inc., outside the submitted work. Sagar S. Patel declares that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Perrin A. Social media usage: 2005–2015. 2015.Google Scholar
  2. 2.
    Pemmaraju N. Editorial overview: emerging importance of social media for real-time communication in the modern medical era. Semin Hematol. 2017;54:175–6.CrossRefGoogle Scholar
  3. 3.
    Center PR. Social media fact sheet. In 2018.Google Scholar
  4. 4.
    Choo EK, Ranney ML, Chan TM, Trueger NS, Walsh AE, Tegtmeyer K, et al. Twitter as a tool for communication and knowledge exchange in academic medicine: a guide for skeptics and novices. Med Teach. 2015;37:411–6.CrossRefGoogle Scholar
  5. 5.
    Grajales FJ III, Sheps S, Ho K, et al. Social media: a review and tutorial of applications in medicine and health care. J Med Internet Res. 2014;16:e13.CrossRefGoogle Scholar
  6. 6.
    Chan T, Trueger NS, Roland D, Thoma B. Evidence-based medicine in the era of social media: scholarly engagement through participation and online interaction. CJEM. 2018;20:3–8.CrossRefGoogle Scholar
  7. 7.
    Markham MJ, Gentile D, Graham DL. Social media for networking, professional development, and patient engagement. Am Soc Clin Oncol Educ Book. 2017;37:782–7.CrossRefGoogle Scholar
  8. 8.
    Chan TM, Thoma B, Radecki R, Topf J, Woo HH, Kao LS, et al. Ten steps for setting up an online journal club. J Contin Educ Heal Prof. 2015;35:148–54.CrossRefGoogle Scholar
  9. 9.
    • Gerds AT, Chan T. Social media in hematology in 2017: dystopia, utopia, or somewhere in-between? Curr Hematol Malig Rep. 2017;12:582–91 Establishes framework of social media use as well as limitations.CrossRefGoogle Scholar
  10. 10.
    • Patel SS, Majhail NS. Twitter use in the hematopoietic cell transplantation community. Curr Hematol Malig Rep. 2018;13:53–8 Focuses on Twitter use in HCT.CrossRefGoogle Scholar
  11. 11.
    Chan TM, Stukus D, Leppink J, Duque L, Bigham BL, Mehta N, et al. Social media and the 21st-century scholar: how you can harness social media to amplify your career. J Am Coll Radiol. 2018;15:142–8.CrossRefGoogle Scholar
  12. 12.
    Tweetreach.com. Tweetreach Snapshot for #bmtsm. In. 2018.
  13. 13.
    Faust J. Medical Twitter’s #ShareAStoryInOneTweet is heartbreaking, self-aggrandizing, and extremely important. In Slate.Google Scholar
  14. 14.
    Institute NC. At the crossroads of social media and clinical trials: a workshop on the future of clinician. Patient and Community Engagement In. 2018.Google Scholar
  15. 15.
    Center MAC. Junior faculty - social media workshop: how social media can increase your academic impact. In. 2018.Google Scholar
  16. 16.
    Hoang PH, Dobbins SE, Cornish AJ, Chubb D, Law PJ, Kaiser M, et al. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms. Leukemia. 2018.Google Scholar
  17. 17.
    • Logan AC. Using social media at national meetings in hematology-optimal use, tips, strategies, and limitations. Curr Hematol Malig Rep. 2017;12:605–10 A review of social media use at national meetings.CrossRefGoogle Scholar
  18. 18.
    June CH, Sadelain M. Chimeric antigen receptor therapy. N Engl J Med. 2018;379:64–73.CrossRefGoogle Scholar
  19. 19.
    •• Pemmaraju N, Thompson MA, Qazilbash M. Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology. Semin Hematol 2017; 54: 189–192. Establishes framework of disease-specific hashtags in hematology and oncology. Google Scholar
  20. 20.
    Katz MS, Utengen A, Anderson PF, Thompson MA, Attai DJ, Johnston C, et al. Disease-specific hashtags for online communication about cancer care. JAMA Oncol. 2016;2:392–4.CrossRefGoogle Scholar
  21. 21.
    Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol. 2016;14:220–2.PubMedGoogle Scholar
  22. 22.
    Pemmaraju N, Utengen A, Gupta V, Kiladjian JJ, Mesa R, Thompson MA. Rare cancers and social media: analysis of Twitter metrics in the first 2 years of a rare-disease community for myeloproliferative neoplasms on social media-#MPNSM. Curr Hematol Malig Rep. 2017;12:598–604.CrossRefGoogle Scholar
  23. 23.
    Attai DJ, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim J, et al. Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine. Semin Hematol. 2017;54:198–204.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Blood & Marrow Transplant Program, Department of Hematology and Medical OncologyTaussig Cancer Institute, Cleveland ClinicClevelandUSA

Personalised recommendations